Immutep Limited

IMMP

$0.37

-4.65%

2026-09-03 16:00:01 EDT-$0.02

Healthcare

Biotechnology

NASDAQ

Active Trading

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its ...

Historical Employee Count of IMMP

Current

Change

+15.91%

Minimum

Maximum

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Jun 30, 2025	51	20-F	Oct 24, 2025	View
Jun 30, 2024	44	20-F	Oct 22, 2024	View
Jun 30, 2023	41	20-F	Oct 24, 2023	View
Jun 30, 2022	35	20-F	Oct 31, 2022	View

Supply Chain of IMMP

Upstream / Downstream / Proxies

Upstream

WuXi Biologics (Cayman) Inc.HKEx:2269Northway BiotechThermo Fisher Scientific Inc. (via Henogen acquisition)NYSE:TMOCell culture media & raw material suppliers (via WuXi Biologics supply chain)

Downstream

Dr. Reddy's Laboratories Ltd.NYSE:RDYEOC PharmaNovartis AGNYSE:NVS Merck & Co., Inc. (MSD)NYSE:MRKMerck KGaAXETRA:MRKPfizer Inc.NYSE:PFE Labcorp Holdings Inc.NYSE:LHCytlimic

Proxies

WuXi Biologics (Cayman) Inc.HKEx:2269 Dr. Reddy's Laboratories Ltd.NYSE:RDY Novartis AGNYSE:NVS

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer